• 1
    Allen, J.G., Atherton, F.R., Hall, M.J., Hassall, C.H., Holmes, S.W., Lambert, R.W., Nisbet, L.J. & Ringrose, P.S. (1978) Phosphonopeptides, a new class of synthetic antibacterial agents. Nature 272, 5658.
  • 2
    Arisawa, M., Ohshima, J., Ohsawa, E. & Maruyama, H.B. (1982) In vitro potentiation of cephalosporins by alafosfalin against urinary tract bacteria. Antimicrob. Agents Chemother. 21, 706710.
  • 3
    Westmacott, D., Hall, M., Hassall, C., Lees, L., Rowe, B. & Ward, L. (1982) Activity of alafosfalin against bacterial pathogens of the gastrointestinal tract in vitro and in vivo. Current chemotherapy and immunotherapy: Proceedings 12th Int. Congr. Chemother. 1, 340342.
  • 4
    Maruyama, H.B., Arisawa, M. & Sawada, T. (1979) Alafosfalin, a new inhibitor of cell wall biosynthesis: in vitro activity against urinary isolates in Japan and potentiation with β-lactams. Antimicrob. Agents Chemother. 16, 444451.
  • 5
    Atherton, F.R., Hall, J.H., Hassall, C.H., Holmes, S.W., Lambert, R.W., Lloyd, W.J. & Ringrose, P.S. (1980) Phosphonopeptide antibacterial agents related to alafosfalin: design, synthesis, and structure-activity relationships. Antimicrob. Agents Chemother. 18, 897905.
  • 6
    Welling, P.G., Kendall, M.J. & Dean, S. (1980) Effect of food on the bioavailability of alafosfalin, a new antibacterial agent. J. Antimicrob. Chemother. 6, 373379.
  • 7
    Kafarski, P. & Lejczak, B. (2001) Aminophosphonic acids of potential medical importance. Curr. Med. Chem. Anti-Canc. Agents 1, 301312.
  • 8
    Tsopelas, C., Penglis, S., Ruszkiewicz, A. & Bartholomeusz, F.D. (2003) [99mTc]Alafosfalin: an antibiotic peptide infection imaging agent. Nucl. Med. Biol. 30, 169175.
  • 9
    Druggan, P. (2002) Improvements in or relating to selective agents for biological cultures. PCT International Application Patent no. WO022785.
  • 10
    Perry, J.D., Riley, G., Gould, F.K., Perez, J.M., Boissier, E., Ouedraogo, R.T. & Freydière, A.M. (2002) Alafosfalin as a selective agent for isolation of Salmonella from clinical samples. J. Clin. Microbiol. 40, 39133916.
  • 11
    Nisbet, T.M. & Payne, J.W. (1982) The characteristics of peptide uptake in Streptococcus faecalis: studies on the transport of natural peptides and antibacterial phosphonopeptides. J. Gen. Microbiol. 128, 13571364.
  • 12
    Atherton, F.R., Hall, M.J., Hassall, C.H., Lambert, R.W., Lloyd, W.J., Lord, A.V., Ringrose, P.S. & Westmacott, D. (1983) Phosphonopeptides as substrates for peptide transport systems and peptidases of Escherichia coli. Antimicrob. Agents Chemother. 24, 522528.
  • 13
    Grappel, S.F., Giovenella, A.J. & Nisbet, L.J. (1985) Activity of a peptidyl prodrug, alafosfalin, against anaerobic bacteria. Antimicrob. Agents Chemother. 27, 961963.
  • 14
    Smith, M.W. & Payne, J.W. (1990) Simultaneous exploitation of different peptide permeases by combinations of synthetic peptide smugglins can lead to enhanced antibacterial activity. FEMS Microbiol. Lett. 58, 311316.
  • 15
    Rubio-Aliaga, I. & Daniel, H. (2002) Mammalian peptide transporters as targets for drug delivery. Trends Pharmacol. Sci. 23, 434440.
  • 16
    Daniel, H. & Rubio-Aliaga, I. (2003) An update on renal peptide transporters. Am. J. Physiol. Renal Physiol. 284, F885F892.
  • 17
    Brandsch, M., Knütter, I. & Leibach, F.H. (2004) The intestinal H+/peptide symporter PEPT1: structure-affinity relationships. Eur. J. Pharm. Sci. 21, 5360.
  • 18
    Daniel, H. & Kottra, G. (2004) The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflugers Arch. 447, 610618.
  • 19
    Brodin, B., Nielsen, C.U., Steffansen, B. & Frokjaer, S. (2002) Transport of peptidomimetic drugs by the intestinal di/tri-peptide transporter, PepT1. Pharmacol. Toxicol. 90, 285296.
  • 20
    Bretschneider, B., Brandsch, M. & Neubert, R. (1999) Intestinal transport of β-lactam antibiotics: analysis of the affinity at the H+/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux. Pharm. Res. 16, 5561.
  • 21
    Nielsen, C.U., Brodin, B., Jorgensen, F.S., Frokjaer, S. & Steffansen, B. (2002) Human peptide transporters: therapeutic applications. Expert Opin. Ther. Patents 12, 13291349.
  • 22
    Ganapathy, M.E., Brandsch, M., Prasad, P.D., Ganapathy, V. & Leibach, F.H. (1995) Differential recognition of β-lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2. J. Biol. Chem. 270, 2567225677.
  • 23
    Neumann, J. & Brandsch, M. (2003) δ-Aminolevulinic acid transport in cancer cells of the human extrahepatic biliary duct. J. Pharmacol. Exp. Ther. 305, 219224.
  • 24
    Brandsch, M., Brandsch, C., Prasad, P.D., Ganapathy, V., Hopfer, U. & Leibach, F.H. (1995) Identification of a renal cell line that constitutively expresses the kidney-specific high-affinity H+/peptide cotransporter. FASEB J. 9, 14891496.
  • 25
    Shu, C., Shen, H., Hopfer, U. & Smith, D.E. (2001) Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: uptake and transport of fosinopril in cell cultures. Drug Metab. Dispos. 29, 13071315.
  • 26
    Börner, V., Fei, Y.-L., Hartrodt, B., Ganapathy, V., Leibach, F.H., Neubert, K. & Brandsch, M. (1998) Transport of amino acid aryl amides by the intestinal H+/peptide cotransport system, PEPT1. Eur. J. Biochem. 255, 698702.
  • 27
    Brandsch, M., Knütter, I., Thunecke, F., Hartrodt, B., Born, I., Börner, V., Hirche, F., Fischer, G. & Neubert, K. (1999) Decisive structural determinants for the interaction of proline derivatives with the intestinal H+/peptide symporter. Eur. J. Biochem. 266, 502508.
  • 28
    Knütter, I., Hartrodt, B., Theis, S., Foltz, M., Rastetter, M., Daniel, H., Neubert, K. & Brandsch, M. (2004) Analysis of the transport properties of side chain modified dipeptides at the mammalian peptide transporter PEPT1. Eur. J. Pharm. Sci. 21, 6167.
  • 29
    Thwaites, D.T., McEwan, G.T.A., Hirst, B.H. & Simmons, N.L. (1993) Transepithelial dipeptide (glycylsarcosine) transport across epithelial monolayers of human Caco-2 cells is rheogenic. Pflügers Arch. 425, 178180.
  • 30
    Terada, T., Sawada, K., Ito, T., Saito, H., Hashimoto, Y. & Inui, K. (2000) Functional expression of novel peptide transporter in renal basolateral membranes. Am. J. Physiol. Renal Physiol. 279, F851F857.
  • 31
    Terada, T., Sawada, K., Saito, H., Hashimoto, Y. & Inui, K. (1999) Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2. Am. J. Physiol. 276, G1435G1441.